It has been demonstrated that downregulated miR-126 increases VEGF-A activity in oral cancer, lung cancer and breast cancer [16, 19, 27] and that miR-126 may act as a tumor suppressor by regulating VEGF-A expression in esophageal cancer. The gene discussed is VEGFA; the disease is breast carcinoma.